*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : FZ2100000
CHEMICAL NAME : 5-beta-Cholan-24-oic acid,
3-alpha,12-alpha-dihydroxy-
CAS REGISTRY NUMBER : 83-44-3
BEILSTEIN REFERENCE NO. : 3219882
REFERENCE : 4-10-00-01608 (Beilstein Handbook Reference)
LAST UPDATED : 199701
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C24-H40-O4
MOLECULAR WEIGHT : 392.64
WISWESSER LINE NOTATION : L E5 B666TJ A1 DQ E1 FY1&2VQ OQ
COMPOUND DESCRIPTOR : Tumorigen
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Cholan-24-oic acid, 3,12-dihydroxy-, (3-alpha,5-beta,12-alpha)-
* Choleic acid
* Cholerebic
* Cholic acid, deoxy-
* Cholorebic
* Degalol
* Deoxycholatic acid
* Deoxycholic acid
* 5-beta-Deoxycholic acid
* Desoxycholic acid
* Desoxycholsaeure
* 3,12-Dihydroxycholanic acid
* 3-alpha,12-alpha-Dihydroxycholanic acid
* 3-alpha,12-alpha-Dihydroxy-5-beta-cholanoic acid
* 3-alpha,12-alpha-Dihydroxycholansaeure
* Droxolan
* l7-beta-(1-Methyl-3-carboxypropyl)-etiocholane-3-alpha,12-alpha-diol
* Pyrochol
* Septochol
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Behavioral - food intake (animal)
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NAIZAM Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara
Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken,
Japan) V.1- 1950- Volume(issue)/page/year: 33,71,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NAIZAM Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara
Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken,
Japan) V.1- 1950- Volume(issue)/page/year: 33,71,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 130 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 20,323,1970
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ZGEMAZ Zeitschrift fuer die Gesamte Experimentelle Medizin. (Berlin, Fed.
Rep. Ger.) V.1-139, 1913-65. For publisher information, see REXMAS.
Volume(issue)/page/year: 52,779,1926
** TUMORIGENIC DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2700 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Skin and Appendages - tumors
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
10,363,1956
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1120 mg/kg/22W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
NATUAS Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736)
V.1- 1869- Volume(issue)/page/year: 145,627,1940
TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1400 mg/kg/22W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
PRLBA4 Proceedings of the Royal Society of London, Series B: Biological
Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76-
1905- Volume(issue)/page/year: 129,439,1940
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 166 mg/kg
SEX/DURATION : female 12-19 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 42,215,1990
** MUTATION DATA **
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 20 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 158,45,1985
TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 2800 umol/L
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year:
60,192,1987
TYPE OF TEST : Sex chromosome loss and nondisjunction
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 100 mg/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 5,447,1984
TYPE OF TEST : Morphological transformation
TEST SYSTEM : Rodent - hamster Embryo
DOSE/DURATION : 7250 ug/L
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 9,177,1981
*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***
NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - 80398
No. of Facilities: 153 (estimated)
No. of Industries: 2
No. of Occupations: 7
No. of Employees: 3527 (estimated)
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - 80398
No. of Facilities: 82 (estimated)
No. of Industries: 2
No. of Occupations: 5
No. of Employees: 2416 (estimated)
No. of Female Employees: 1577 (estimated)
*** STATUS IN U.S. ***
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Chloric acid, sodium salt, mixt. with urea
| 102340-92-1 |
Chloric acid, thallium(1+) salt
| 13453-30-0 |
Chloriertes camphenSUBSTANCE DEFINITION :Consists of a mixture of chlorinated camphene with 67-69% chlorineREFERENCE :85GYAV "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einerToxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R.,Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 Volume(issue)/page/year:-,50,1971
| 13453-30-0 |
Chlorinated poly(vinyl chloride), pyrolyzate
| 13453-30-0 |
5-beta-Card-20(22)-enolide,3-beta-((2,6-dideoxy-3,4-O-(1-phenylmethyl)propylidene)-beta-D- ribo-hexopyranosyl)-5,14-dihydroxy-19-oxo-
| 35811-18-8 |
Chlorinated trisodium phosphate
| 11084-85-8 |
Chlorine
| 7782-50-5 |
Chlorine fluoride
| 7790-91-2 |
Chlorine fluoride (ClF5)
| 13637-63-3 |
Chlorine oxide
| 10049-04-4 |
Chlorisofos
| 76774-73-7 |
Chlorite
| 14998-27-7 |
Chlorocarcin A, dihydrochloride, hydrate
| 14998-27-7 |
Chlorocarcin B
| 59493-95-7 |
Chloroform
| 67-66-3 |
Card-20(22)-enolide,3-((2,6-dideoxy-4-O-beta-D-xylopyranosyl-beta-D-ribo-hexopyranosyl)oxy)- 5,14-dihydroxy-19-oxo-,(3-beta,5-beta)-
| 630-65-9 |
Chloroparaffin XP-470
| 630-65-9 |
Chlorophyll
| 1406-65-1 |
Chloroprene rubber
| 1406-65-1 |
Chlorostatin
| 37246-59-6 |
Chlorosulfuric acid
| 7790-94-5 |
Chlorosulfuric acid, (2-chloroethyl) ester
| 13891-58-2 |
Chlorosulfuric acid, (2-fluoroethyl) ester
| 371-94-8 |
Chlorothricin, 2(A)-hydroxy-, (2(A)R)-, (9CI)
| 111810-18-5 |
Chlorous acid, silver(1+) salt
| 7783-91-7 |
Chocolate Brown FB
| 12236-46-3 |
Card-20(22)-enolide,3-((diethylaminoacetyl)oxy)-5,14-dihydroxy-19-oxo-,(3-beta,5-beta)-
| 63979-66-8 |
Choerospondias axillaris (roxb.) Burtt. et Hill,fruit extract
| 63979-66-8 |
Choji (Japanese)SUBSTANCE DEFINITION :Crude drug extract from Syzygium aromaticaREFERENCE :MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AEAmsterdam, Netherlands) V.1- 1964-
| 63979-66-8 |
Cholan-24-oic acid, 3,7-bis(sulfooxy)-, trisodiumsalt, (3-alpha,5-beta,7-beta)-
| 89232-83-7 |
5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy-
| 474-25-9 |
5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy-
| 128-13-2 |
5-beta-Cholan-24-oic acid, 3-alpha,6-alpha-dihydroxy-
| 83-49-8 |
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-
| 83-44-3 |
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- compd. with acenaphthene
| 83-44-3 |
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, compd. withcholanthrene, 3-methyl-
| 83-44-3 |
5-beta-Cholan-24-oic acid,3-alpha-12-alpha-dihydroxy-, compound withdibenz(a,h)anthracene
| 83-44-3 |
5-alpha-Card-20(22)-enolide, 3-alpha,14-dihydroxy-
| 466-08-0 |
5-beta-Cholan-24-oic acid,3-alpha,7-alpha-dihydroxy-, monosodium salt
| 2646-38-0 |
Cholan-24-oic acid, 3,7-dihydroxy-12-oxo-, sodiumsalt
| 2646-38-0 |
Cholan-24-oic acid, 3,12-dihydroxy-7-oxo-, sodiumsalt
| 2646-38-0 |
Cholan-24-oic acid, 7,12-dihydroxy-3-oxo-, sodiumsalt
| 2646-38-0 |
5-beta-Cholan-24-oic acid,3-alpha,6-alpha-dihydroxy-, sodium salt
| 31687-62-4 |
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, sodium salt
| 302-95-4 |
5-beta-Cholan-24-oic acid, 3,12-dioxo-
| 2958-05-6 |
Cholan-24-oic acid, 3,7-dioxo-12-hydroxy-, sodiumsalt
| 2958-05-6 |
Cholan-24-oic acid, 3,12-dioxo-7-hydroxy-, sodiumsalt
| 2958-05-6 |
Cholan-24-oic acid, 7,12-dioxo-3-hydroxy-, sodiumsalt
| 2958-05-6 |
5-beta-Card-20(22)-enolide, 3-alpha,14-dihydroxy-
| 545-52-8 |
5-beta-Cholan-24-oic acid, 3,6-dioxo-, sodium salt
| 545-52-8 |
|
|